197 related articles for article (PubMed ID: 31230083)
1. Implementing Psoriatic Arthritis Disease Activity Score-guided treat-to-target in psoriatic arthritis routine clinical practice: (im)possible?
Mulder MLM; den Broeder AA; van Ginneken BTJ; Mahler EAM; van den Hoogen FHJ; Vriezekolk JE; Wenink MH
Rheumatology (Oxford); 2019 Dec; 58(12):2330-2331. PubMed ID: 31230083
[No Abstract] [Full Text] [Related]
2. Psoriatic arthritis: is it time to treat-to-target or target to treat?
Lubrano E; Perrotta FM
Clin Rheumatol; 2017 Dec; 36(12):2633-2635. PubMed ID: 29067586
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Response to Treatment, Remission, and Minimal Disease Activity in Axial Psoriatic Arthritis Treated with Tumor Necrosis Factor Inhibitors.
Lubrano E; Parsons WJ; Perrotta FM
J Rheumatol; 2016 May; 43(5):918-23. PubMed ID: 26980581
[TBL] [Abstract][Full Text] [Related]
4. What Should Be the Primary Target of "Treat to Target" in Psoriatic Arthritis?
Coates LC; Lubrano E; Perrotta FM; Emery P; Conaghan PG; Helliwell PS
J Rheumatol; 2019 Jan; 46(1):38-42. PubMed ID: 30219765
[TBL] [Abstract][Full Text] [Related]
5. Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?
Tucker LJ; Ye W; Coates LC
Curr Rheumatol Rep; 2018 Sep; 20(11):71. PubMed ID: 30229387
[TBL] [Abstract][Full Text] [Related]
6. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
[TBL] [Abstract][Full Text] [Related]
7. Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.
Perrotta FM; Marchesoni A; Lubrano E
J Rheumatol; 2016 Feb; 43(2):350-5. PubMed ID: 26669925
[TBL] [Abstract][Full Text] [Related]
8. Minimal Disease Activity as a Treatment Target in Psoriatic Arthritis: A Review of the Literature.
Gossec L; McGonagle D; Korotaeva T; Lubrano E; de Miguel E; Østergaard M; Behrens F
J Rheumatol; 2018 Jan; 45(1):6-13. PubMed ID: 29142032
[TBL] [Abstract][Full Text] [Related]
9. Clinical remission in rheumatoid arthritis and psoriatic arthritis.
Lubrano E; Mesina F; Caporali R
Clin Exp Rheumatol; 2018; 36(5):900-910. PubMed ID: 29600949
[TBL] [Abstract][Full Text] [Related]
10. Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis.
Queiro R; Cañete JD; Montilla C; Abad MA; Montoro M; Gómez S; Cábez A;
J Rheumatol; 2019 Jul; 46(7):710-715. PubMed ID: 30709957
[TBL] [Abstract][Full Text] [Related]
11. Residual patient-reported burden in 444 patients with psoriatic arthritis in remission or low disease: A cross-sectional analysis.
Lucasson F; Balanescu A; Kiltz U; Leung YY; Aydin SZ; Gaydukova I; Lubrano E; Coates LC; de Wit M; Orbai AM; Gossec L
Joint Bone Spine; 2022 Oct; 89(5):105372. PubMed ID: 35257864
[No Abstract] [Full Text] [Related]
12. Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic Arthritis.
Sheane BJ; Thavaneswaran A; Gladman DD; Chandran V
J Rheumatol; 2016 Sep; 43(9):1718-23. PubMed ID: 27422895
[TBL] [Abstract][Full Text] [Related]
13. Remission and low disease activity in psoriatic arthritis publications: a systematic literature review with meta-analysis.
Hagège B; Tan E; Gayraud M; Fautrel B; Gossec L; Mitrovic S
Rheumatology (Oxford); 2020 Aug; 59(8):1818-1825. PubMed ID: 32118267
[TBL] [Abstract][Full Text] [Related]
14. Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic Arthritis.
Atzeni F; Costa L; Caso F; Scarpa R; Sarzi-Puttini P
J Rheumatol Suppl; 2015 Nov; 93():79-81. PubMed ID: 26523064
[TBL] [Abstract][Full Text] [Related]
15. Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis.
Wervers K; Vis M; Tchetveriko I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Luime JJ
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1764-1770. PubMed ID: 29609220
[TBL] [Abstract][Full Text] [Related]
16. Early psoriatic arthritis.
Gladman DD
Rheum Dis Clin North Am; 2012 May; 38(2):373-86. PubMed ID: 22819090
[TBL] [Abstract][Full Text] [Related]
17. [Psoriatic arthritis: what the dermatologist needs to know, Part 2].
López-Ferrer A; Torrente-Segarra V; Puig L
Actas Dermosifiliogr; 2010 Nov; 101(9):742-8. PubMed ID: 21034704
[TBL] [Abstract][Full Text] [Related]
18. Psoriatic arthritis.
Durham LE; Taams LS; Kirkham BW
Br J Hosp Med (Lond); 2016 Jul; 77(7):C102-8. PubMed ID: 27388392
[No Abstract] [Full Text] [Related]
19. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
[TBL] [Abstract][Full Text] [Related]
20. Development of a preliminary composite disease activity index in psoriatic arthritis.
Mumtaz A; Gallagher P; Kirby B; Waxman R; Coates LC; Veale J D; Helliwell P; FitzGerald O
Ann Rheum Dis; 2011 Feb; 70(2):272-7. PubMed ID: 21115550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
